Autotransfusion Devices Market Report 2024-2033 | Share, Trends, Growth Demand, Overview

The autotransfusion devices market size has grown strongly in recent years. It will grow from $1.17 billion in 2023 to $1.24 billion in 2024 at a compound annual growth rate (CAGR) of 6.0%. The growth in the historic period can be attributed to increase in surgical procedures, cardiovascular disease prevalence, orthopedic surgeries and joint replacements, focus on patient safety, efforts to reduce blood transfusion costs.

The autotransfusion devices market size is expected to see strong growth in the next few years. It will grow to $1.57 billion in 2028 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to growing geriatric population, expansion of ambulatory surgical centers, focus on blood conservation in obstetrics, adoption in developing healthcare markets. Major trends in the forecast period include technological advancements in blood processing, integration of advanced sensors, customization for different procedures, single-donor closed-loop systems, miniaturization of devices.

Market Overview -
Autotransfusion devices refer to tools used to collect and reinfuse a patient's blood during a medical procedure, instead of using donated blood. This process is also known as autologous blood transfusion and can help reduce the need for allogenic (separate-donor) blood transfusions. Autotransfusion devices are commonly used in trauma patients in the emergency department and during surgeries.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=10275&type=smp

Autotransfusion Device Market Soars Amidst Rising Prevalence Of Cardiovascular Diseases

Increasing prevalence of cardiovascular diseases is expected to propel the growth of the autotransfusion device market going forward. Cardiovascular diseases (CVDs) refer to a group of disorders affecting the heart and blood vessels. Autotransfusion devices contribute to the trend of minimizing the use of allogeneic blood transfusions. Allogeneic transfusions involve donated blood from external sources, and autotransfusion allows for the reinfusion of the patient's own blood, reducing the risk of transfusion reactions and complications associated with donor blood. For instance, according to the Heart Disease and Stroke Statistics-2022 Update report by American Heart Association, a US-based non-profit organization, cardiovascular diseases (CVDs) remain the leading cause of death globally, taking an estimated 17.9 million lives each year. Therefore, the increasing prevalence of cardiovascular diseases is driving the growth of the autotransfusion device market.

Competitive Landscape -
Major companies operating in the autotransfusion devices market report are Becton Dickinson And Company, Medtronic plc, LivaNova plc, Haemonetics Corporation, Fresenius SE & Co KGaA, Terumo Corporation, Asahi Kasei Medical Co. Ltd., Miltenyi Biotec, B. Braun Melsungen AG, GE HealthCare Technologies Inc., Cerus Corporation, Stryker Corporation, Atrium Medical Technologies, Brightwake Ltd., Getinge AB, Advancis Surgical, Beijing ZKSK Technology Co. Ltd., Braile Biomédica, Redax S.p.A., Teleflex Incorporated, Zimmer Biomet Holdings Inc., Gen World Medical Devices Corporation, Soma Technology International LLC, ProCell Surgical Inc., Beijing Jingjing Medical Equipment Co. Ltd., Johnson & Johnson Inc., Sorin Group, Baxter International Inc., Dideco, Nipro Corporation, Advantech Wireless Technologies Inc.

Omnicell And Fresenius Kabi Forge Strategic Partnership To Elevate Controlled Substance Management In Autotransfusion Devices
Major companies operating in the autotransfusion devices market are undergoing strategic partnerships to enhance management of controlled substances. Collaboration allows companies to combine their expertise and resources for the development of advanced technologies and innovative solutions in autotransfusion devices. For instance, in November 2021, Omnicell, a US-based healthcare company and Fresenius Kabi, a Germany-based pharmaceutical company joined forces to improve controlled substance management in healthcare settings. Their collaboration aims to streamline the management of autotransfusion devices and other controlled substances, ensuring patient safety and regulatory compliance.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/autotransfusion-devices-global-market-report

Key Segments -

The autotransfusion devices market covered in this report is segmented -

1) By Product Type: Autotransfusion Systems, Consumables And Accessories
2) By Application: Cardiovascular Surgeries, Orthopedic Surgeries, Neurological Surgeries, Obstetrics And Gynecology Surgeries, Other Applications
3) By End-Use: Hospitals, Specialty Clinics, Other End Users

Key highlights covered in the report -

1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.